Acuta Capital Partners, LLC
23 holdingsFiling period: 2026-06-30Current AUM: $100.8Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PRAX | Praxis Precision Medicines I | 82.8K | $27.7M | $23.0M | 22.81% | -2,105 | 2026-06-30 |
| 2 | WHWK | Whitehawk Therapeutics Inc | 4.69M | $21.5M | $14.7M | 14.55% | +1.28M | 2026-06-30 |
| 3 | TNGX | Tango Therapeutics Inc | 390.9K | $12.2M | $8.4M | 8.34% | -50,882 | 2026-06-30 |
| 4 | STRO | Sutro Biopharma Inc | 270.3K | $9.0M | $2.6M | 2.58% | +826 | 2026-06-30 |
| 5 | AVBP | Arrivent Biopharma Inc | 218.7K | $7.6M | $3.0M | 2.96% | -- | 2026-06-30 |
| 6 | FDMT | 4D Molecular Therapeutics Inc | 507.8K | $6.8M | $6.2M | 6.17% | -- | 2026-06-30 |
| 7 | DRUG | Bright Minds Biosciences Inc | 92.7K | $6.5M | $2.1M | 2.12% | -19,251 | 2026-06-30 |
| 8 | OCUL | Ocular Therapeutix Inc | 532.5K | $5.2M | $3.5M | 3.48% | -59,627 | 2026-06-30 |
| 9 | ERAS | Erasca Inc | 265.2K | $4.9M | $3.8M | 3.79% | -89,376 | 2026-06-30 |
| 10 | SRZN | Surrozen Inc | 173.4K | $4.5M | $5.4M | 5.33% | +548 | 2026-06-30 |
| 11 | ARGX | Argen SE - ADR | 4.7K | $4.4M | $4.4M | 4.33% | +15 | 2026-06-30 |
| 12 | MLTX | Moonlake Immunotherapeutics | 215.7K | $4.2M | $2.5M | 2.47% | +23.9K | 2026-06-30 |
| 13 | DSGN | Design Therapeutics Inc | 282.6K | $4.1M | $2.9M | 2.86% | +136.7K | 2026-06-30 |
| 14 | NERV | Minerva Neurosciences | 709.5K | $3.9M | $1.7M | 1.70% | -- | 2026-06-30 |
| 15 | TSHA | Taysha Gene Therapies Inc | 561.8K | $3.8M | $2.4M | 2.41% | +122.3K | 2026-06-30 |
| 16 | AVLN | Avalyn Pharma Inc | 115.0K | $3.8M | $3.4M | 3.33% | -- | 2026-06-30 |
| 17 | AVTX | Avalo Therapeutics Inc | 186.3K | $3.4M | $1.3M | 1.28% | +125.5K | 2026-06-30 |
| 18 | AMLX | Amylyx Pharmaceuticals Inc | 168.1K | $3.0M | $5.0M | 4.92% | +17.0K | 2026-06-30 |
| 19 | ARTV | Artiva Biotherapeutics Inc | 260.4K | $2.5M | $1.1M | 1.07% | -- | 2026-06-30 |
| 20 | CMPX | Compass Therapeutics Inc | 595.2K | $1.3M | $451K | 0.45% | -253,863 | 2026-06-30 |
| 21 | UTHR | United Therapeutics Corp | 2.2K | $1.2M | $1.2M | 1.24% | -- | 2026-06-30 |
| 22 | CTNM | Contineum Therapeutics Inc-A | 63.1K | $1.0M | $601K | 0.60% | -- | 2026-06-30 |
| 23 | LBRX | LB Pharmaceuticals Inc | 28.9K | $938K | $1.2M | 1.20% | -- | 2026-06-30 |
← Scroll →